Clinical Trial Update: A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Stellate Ganglion Block in preventing atrial fibrillation; Phases 2 and 3 have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 2, Phase 3 | Status: COMPLETED